Vascular compromise secondary to fillers injection: Minimizing sequelae

Abstract - 596 PDF - 300
Serag Monier Zidan

Abstract


The use of filler injections for facial rejuvenation and sculpturing has become a keystone of esthetic medicine.

Keywords


Fillers; filler complications; hyaluronidase

Full Text:

PDF

References


Ozturk CN, Li Y, Tung R, Parker L, Piliang MP, et al. Complications following injection of soft-tissue fillers. Aesthet Surg J 2013; 33(6): 862–877. doi: 10.1177/1090-820X13493638.

Girolamo MD, Mattei M, Signore A, Grippaudo FR. MRI in evaluation of facial dermal fillers in normal and complicated cases. Euro Radiol 2015; 25(5): 1431–1442. doi: 10.1007/s00330-014-3513-2.

Beleznay K, Humphrey S, Carruther JDA, Carruthers A. Vascular compromise from soft tissue augmentation. J Clin Aesthet Dermatol 2014; 7(9): 37–43.

Hirsch RJ, Lupo M, Cohen JL, Duffy D. Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase. J Drugs Dermatol 2007; 6(3): 325–328.

Kim JH, Ahn DK, Jeong HS, Suh IS. Treatment algorithm of complications after filler injection: Based on wound healing process. J Korean Med Sci 2014; 29(Suppl 3): S176–S182. doi: 10.3346/jkms.2014.29.S3.S176.

Sclafani AP, Fagien S. Treatment of injectable soft tissue filler complications. Dermatol Surg 2009; 35(Suppl 2): 1672–1680. doi: 10.1111/j.1524-4725.2009.01346.x.

Dayan SH, Arkins JP, Mathison CC. Management of impending necrosis associated with soft tissue filler injections. J Drugs Dermatol 2011; 10(9): 1007–1012.


Refbacks

  • There are currently no refbacks.